Related Experiment Video
Updated: May 27, 2026

Wild-type Blocking PCR Combined with Direct Sequencing as a Highly Sensitive Method for Detection of Low-Frequency Somatic Mutations
Published on: March 29, 2017
Second malignancies among Waldenstrom macroglobulinemia patients: small samples and sparse data
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Quantum chemical study of gas-phase reactions of isoprene with OH radicals producing highly oxidised second-generation products.
Journal of molecular modeling·2021
Parental risk perception and influenza vaccination of children in daycare centres.
Epidemiology and infection·2013
Effect of trabectedin on the QT interval in patients with advanced solid tumor malignancies.
Cancer chemotherapy and pharmacology·2011
Clonal cytogenetic changes and myeloma relapse after reduced intensity conditioning allogeneic transplantation.
Bone marrow transplantation·2006
SACI-IO HR+: A randomized phase II trial of sacituzumab govitecan with or without pembrolizumab in patients with metastatic hormone receptor-positive/HER2-negative breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Becotatug Vedotin for Recurrent/Metastatic Nasopharyngeal Carcinoma (Magic-M001): A Multicenter, Randomized Trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Prompt-directed ambient artificial intelligence for automated multidisciplinary tumor board documentation.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
GLP-1 receptor agonist use and cancer risk in obese nondiabetic adults.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Multimodal Artificial Intelligence Prediction of Abiraterone Efficacy in Two STAMPEDE Phase 3 Trials of Non-Metastatic Very High-Risk Prostate Cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Final outcomes of the SOFT and TEXT phase III trials in premenopausal hormone receptor-positive early breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2026